nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosamprenavir—Reaction gastrointestinal—Docetaxel—head and neck cancer	0.0584	0.0584	CcSEcCtD
Fosamprenavir—Inflammation—Fluorouracil—head and neck cancer	0.0279	0.0279	CcSEcCtD
Fosamprenavir—Acute coronary syndrome—Vinblastine—head and neck cancer	0.0227	0.0227	CcSEcCtD
Fosamprenavir—Myocardial infarction—Vinblastine—head and neck cancer	0.0226	0.0226	CcSEcCtD
Fosamprenavir—Neutropenia—Hydroxyurea—head and neck cancer	0.022	0.022	CcSEcCtD
Fosamprenavir—Haemoglobin—Vinblastine—head and neck cancer	0.0208	0.0208	CcSEcCtD
Fosamprenavir—Haemorrhage—Vinblastine—head and neck cancer	0.0207	0.0207	CcSEcCtD
Fosamprenavir—Inflammation—Docetaxel—head and neck cancer	0.0201	0.0201	CcSEcCtD
Fosamprenavir—Haemoglobin—Hydroxyurea—head and neck cancer	0.019	0.019	CcSEcCtD
Fosamprenavir—Haemorrhage—Hydroxyurea—head and neck cancer	0.0189	0.0189	CcSEcCtD
Fosamprenavir—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.0149	0.0149	CcSEcCtD
Fosamprenavir—Myocardial infarction—Fluorouracil—head and neck cancer	0.0148	0.0148	CcSEcCtD
Fosamprenavir—Anorexia—Vinblastine—head and neck cancer	0.014	0.014	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.0139	0.0139	CcSEcCtD
Fosamprenavir—Haemoglobin—Fluorouracil—head and neck cancer	0.0136	0.0136	CcSEcCtD
Fosamprenavir—Haemorrhage—Fluorouracil—head and neck cancer	0.0136	0.0136	CcSEcCtD
Fosamprenavir—Nervous system disorder—Hydroxyurea—head and neck cancer	0.0131	0.0131	CcSEcCtD
Fosamprenavir—Skin disorder—Hydroxyurea—head and neck cancer	0.013	0.013	CcSEcCtD
Fosamprenavir—Anorexia—Hydroxyurea—head and neck cancer	0.0128	0.0128	CcSEcCtD
Fosamprenavir—Decreased appetite—Vinblastine—head and neck cancer	0.0128	0.0128	CcSEcCtD
Fosamprenavir—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.0128	0.0128	CcSEcCtD
Fosamprenavir—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.0125	0.0125	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Vinblastine—head and neck cancer	0.012	0.012	CcSEcCtD
Fosamprenavir—Decreased appetite—Hydroxyurea—head and neck cancer	0.0116	0.0116	CcSEcCtD
Fosamprenavir—Abdominal pain—Vinblastine—head and neck cancer	0.0116	0.0116	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.0116	0.0116	CcSEcCtD
Fosamprenavir—Fatigue—Hydroxyurea—head and neck cancer	0.0115	0.0115	CcSEcCtD
Fosamprenavir—Neutropenia—Docetaxel—head and neck cancer	0.0114	0.0114	CcSEcCtD
Fosamprenavir—Hypersensitivity—Vinblastine—head and neck cancer	0.0108	0.0108	CcSEcCtD
Fosamprenavir—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.0108	0.0108	CcSEcCtD
Fosamprenavir—Acute coronary syndrome—Docetaxel—head and neck cancer	0.0108	0.0108	CcSEcCtD
Fosamprenavir—Myocardial infarction—Docetaxel—head and neck cancer	0.0107	0.0107	CcSEcCtD
Fosamprenavir—Body temperature increased—Hydroxyurea—head and neck cancer	0.0106	0.0106	CcSEcCtD
Fosamprenavir—Asthenia—Vinblastine—head and neck cancer	0.0105	0.0105	CcSEcCtD
Fosamprenavir—Myalgia—Fluorouracil—head and neck cancer	0.0101	0.0101	CcSEcCtD
Fosamprenavir—Diarrhoea—Vinblastine—head and neck cancer	0.0101	0.0101	CcSEcCtD
Fosamprenavir—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00987	0.00987	CcSEcCtD
Fosamprenavir—Haemoglobin—Docetaxel—head and neck cancer	0.00985	0.00985	CcSEcCtD
Fosamprenavir—Haemorrhage—Docetaxel—head and neck cancer	0.0098	0.0098	CcSEcCtD
Fosamprenavir—Dizziness—Vinblastine—head and neck cancer	0.00971	0.00971	CcSEcCtD
Fosamprenavir—Urinary tract disorder—Docetaxel—head and neck cancer	0.00967	0.00967	CcSEcCtD
Fosamprenavir—Connective tissue disorder—Docetaxel—head and neck cancer	0.00963	0.00963	CcSEcCtD
Fosamprenavir—Asthenia—Hydroxyurea—head and neck cancer	0.00961	0.00961	CcSEcCtD
Fosamprenavir—Urethral disorder—Docetaxel—head and neck cancer	0.0096	0.0096	CcSEcCtD
Fosamprenavir—Nervous system disorder—Fluorouracil—head and neck cancer	0.00946	0.00946	CcSEcCtD
Fosamprenavir—Vomiting—Vinblastine—head and neck cancer	0.00934	0.00934	CcSEcCtD
Fosamprenavir—Erythema multiforme—Docetaxel—head and neck cancer	0.00926	0.00926	CcSEcCtD
Fosamprenavir—Headache—Vinblastine—head and neck cancer	0.0092	0.0092	CcSEcCtD
Fosamprenavir—Anorexia—Fluorouracil—head and neck cancer	0.00919	0.00919	CcSEcCtD
Fosamprenavir—Diarrhoea—Hydroxyurea—head and neck cancer	0.00917	0.00917	CcSEcCtD
Fosamprenavir—Cardiac disorder—Docetaxel—head and neck cancer	0.00909	0.00909	CcSEcCtD
Fosamprenavir—Dizziness—Hydroxyurea—head and neck cancer	0.00886	0.00886	CcSEcCtD
Fosamprenavir—Immune system disorder—Docetaxel—head and neck cancer	0.00885	0.00885	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00878	0.00878	CcSEcCtD
Fosamprenavir—Nausea—Vinblastine—head and neck cancer	0.00872	0.00872	CcSEcCtD
Fosamprenavir—Malnutrition—Docetaxel—head and neck cancer	0.00853	0.00853	CcSEcCtD
Fosamprenavir—Vomiting—Hydroxyurea—head and neck cancer	0.00852	0.00852	CcSEcCtD
Fosamprenavir—Rash—Hydroxyurea—head and neck cancer	0.00845	0.00845	CcSEcCtD
Fosamprenavir—Dermatitis—Hydroxyurea—head and neck cancer	0.00844	0.00844	CcSEcCtD
Fosamprenavir—Headache—Hydroxyurea—head and neck cancer	0.00839	0.00839	CcSEcCtD
Fosamprenavir—Decreased appetite—Fluorouracil—head and neck cancer	0.00838	0.00838	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00832	0.00832	CcSEcCtD
Fosamprenavir—Nausea—Hydroxyurea—head and neck cancer	0.00796	0.00796	CcSEcCtD
Fosamprenavir—Body temperature increased—Fluorouracil—head and neck cancer	0.00762	0.00762	CcSEcCtD
Fosamprenavir—Myalgia—Docetaxel—head and neck cancer	0.00726	0.00726	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00721	0.00721	CcSEcCtD
Fosamprenavir—Hypersensitivity—Fluorouracil—head and neck cancer	0.0071	0.0071	CcSEcCtD
Fosamprenavir—Nervous system disorder—Docetaxel—head and neck cancer	0.00682	0.00682	CcSEcCtD
Fosamprenavir—Pruritus—Fluorouracil—head and neck cancer	0.00682	0.00682	CcSEcCtD
Fosamprenavir—Skin disorder—Docetaxel—head and neck cancer	0.00676	0.00676	CcSEcCtD
Fosamprenavir—Anorexia—Docetaxel—head and neck cancer	0.00663	0.00663	CcSEcCtD
Fosamprenavir—Diarrhoea—Fluorouracil—head and neck cancer	0.0066	0.0066	CcSEcCtD
Fosamprenavir—Dizziness—Fluorouracil—head and neck cancer	0.00638	0.00638	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00634	0.00634	CcSEcCtD
Fosamprenavir—Vomiting—Fluorouracil—head and neck cancer	0.00613	0.00613	CcSEcCtD
Fosamprenavir—Rash—Fluorouracil—head and neck cancer	0.00608	0.00608	CcSEcCtD
Fosamprenavir—Dermatitis—Fluorouracil—head and neck cancer	0.00607	0.00607	CcSEcCtD
Fosamprenavir—Decreased appetite—Docetaxel—head and neck cancer	0.00605	0.00605	CcSEcCtD
Fosamprenavir—Headache—Fluorouracil—head and neck cancer	0.00604	0.00604	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00601	0.00601	CcSEcCtD
Fosamprenavir—Fatigue—Docetaxel—head and neck cancer	0.006	0.006	CcSEcCtD
Fosamprenavir—Nausea—Fluorouracil—head and neck cancer	0.00573	0.00573	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00569	0.00569	CcSEcCtD
Fosamprenavir—Abdominal pain—Docetaxel—head and neck cancer	0.0055	0.0055	CcSEcCtD
Fosamprenavir—Body temperature increased—Docetaxel—head and neck cancer	0.0055	0.0055	CcSEcCtD
Fosamprenavir—Hypersensitivity—Docetaxel—head and neck cancer	0.00513	0.00513	CcSEcCtD
Fosamprenavir—Asthenia—Docetaxel—head and neck cancer	0.00499	0.00499	CcSEcCtD
Fosamprenavir—Pruritus—Docetaxel—head and neck cancer	0.00492	0.00492	CcSEcCtD
Fosamprenavir—Diarrhoea—Docetaxel—head and neck cancer	0.00476	0.00476	CcSEcCtD
Fosamprenavir—Dizziness—Docetaxel—head and neck cancer	0.0046	0.0046	CcSEcCtD
Fosamprenavir—Vomiting—Docetaxel—head and neck cancer	0.00442	0.00442	CcSEcCtD
Fosamprenavir—Rash—Docetaxel—head and neck cancer	0.00439	0.00439	CcSEcCtD
Fosamprenavir—Dermatitis—Docetaxel—head and neck cancer	0.00438	0.00438	CcSEcCtD
Fosamprenavir—Headache—Docetaxel—head and neck cancer	0.00436	0.00436	CcSEcCtD
Fosamprenavir—Nausea—Docetaxel—head and neck cancer	0.00413	0.00413	CcSEcCtD
